Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1601 to 1650 of 2518

TitleReference numberPublishedLast updated
High-throughput non-invasive prenatal testing for fetal RHD genotypeDG25
Minimal change disease and focal segmental glomerulosclerosis in adults: rituximabES1
Physical health of people in prisonNG57
Psychosis and schizophrenia in children and young people: recognition and managementCG155
Needle-free arterial non-injectable connectorMIB85
Elbasvir–grazoprevir for treating chronic hepatitis CTA413
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanomaTA414
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitorTA415
Coeliac diseaseQS134
Children's attachmentQS133
Single-incision short sling mesh insertion for stress urinary incontinence in womenIPG566
Woundchek Protease Status for assessing elevated protease status in chronic woundsMIB83
Miniature lens system implantation for advanced age-related macular degenerationIPG565
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406
Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitorsTA407
Pegaspargase for treating acute lymphoblastic leukaemiaTA408
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionTA409
Talimogene laherparepvec for treating unresectable metastatic melanomaTA410
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancerTA411
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastasesTA412
Intravenous fluid therapy in children and young people in hospitalQS131
Social care for older people with multiple long-term conditionsQS132
Multimorbidity: clinical assessment and managementNG56
Harmful sexual behaviour among children and young peopleNG55
QuikRead go for C-reactive protein testing in primary careMIB78
FLEXISEQ for osteoarthritisMIB80
Alere Afinion CRP for C-reactive protein testing in primary careMIB81
Mental health problems in people with learning disabilities: prevention, assessment and managementNG54
ContraceptionQS129
Transition between inpatient mental health settings and community or care home settingsNG53
Stable angina: managementCG126
Acute upper gastrointestinal bleeding in over 16s: managementCG141
Axxent electronic brachytherapy system for early stage breast cancerMIB76
OSNA for colon cancer stagingMIB77
Bosutinib for previously treated chronic myeloid leukaemiaTA401
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatinTA402
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancerTA403
Degarelix for treating advanced hormone-dependent prostate cancerTA404
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxelTA391
Early years: promoting health and wellbeing in under 5sQS128
Palliative care for adults: strong opioids for pain reliefCG140
Motor neurone diseaseQS126
Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillationIPG563
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenTA259
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA387
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blastsTA399
Nivolumab in combination with ipilimumab for treating advanced melanomaTA400
QTUG for assessing falls risk and frailtyMIB73
Stretta System for gastro-oesophageal reflux diseaseMIB74

Results per page

  1. 10
  2. 25
  3. 50
  4. All